Navigation Links
NORD Calls for Immediate End to Lifetime Insurance Caps
Date:12/14/2009

WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ -- The National Organization for Rare Disorders (NORD) today called upon Congress to put an immediate end to lifetime and annual health insurance caps. In a full-page ad in The Politico, a newspaper distributed widely on Capitol Hill, NORD said the current Senate health reform bill includes loopholes that would allow caps to continue for most Americans, contrary to what many people believe.

"NORD supports health care reform and welcomes the promises made by President Obama and Congress to eliminate lifetime and annual caps," said NORD President Peter L. Saltonstall. "However, under the current version of the Senate bill, caps would continue for several years for many people and would never be eliminated for others."

Private insurers often set lifetime or annual caps on the amount of health care coverage an individual may have. For Americans with chronic diseases, rare disorders, or major medical crises, this can lead to financial crisis or bankruptcy when insurance benefits are exhausted.

The health care reform debate has focused a spotlight on this problem. President Obama promised this fall that the caps would be eliminated under health reform, noting that insurance companies would "no longer be able to place some arbitrary cap on the amount of coverage you can receive in a given year or a lifetime." Originally, the Senate health reform debate also advocated eliminating the caps.

However, the current version of the Senate bill provides for "grandfathering" existing insurance plans so that existing plans would be subject to annual lifetime caps indefinitely. The bill also allows self-insured plans to impose annual or lifetime caps indefinitely, which means that many people with employer-provided insurance would still be subject to caps. Even when the bill would require eliminating caps, it would not require doing so for several years.


'/>"/>
SOURCE National Organization for Rare Disorders (NORD)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech
2. Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It Political Harassment of Workers
3. Medtronic, Inc. Recalls Quick-Set Infusion Sets
4. GAA Calls on President Obama to Act on the Reality of AIDS
5. GSI Group Calls Shareholders Meeting
6. RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care
7. Attorney Fred Pritzker Calls for Meaningful Food Safety Reform in Light of Food Poisoning Complications
8. FRC Calls on President Obama, Speaker Pelosi, and Senator Reid to Repudiate Diana DeGettes Religious Bigotry
9. VoiceNation Calls on TASterix as Their CRM Solution
10. AMA Calls on Congress to Pass H.R. 3961, Access to Care for Seniors and Military Families at Stake
11. Conference of International Experts Calls for a Focus on Well-Being and The Person in Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Wallingford, CT (PRWEB) June 03, 2015 ... devices, announces today since June has been designated as ... Company commends the Tucson, AZ. Police Department for its ... that its personnel utilized their Individual First Aid Kits ... help civilians involved in shootings, stabbings or traffic accidents. ...
(Date:6/3/2015)... Researchers at the University of Western Australia compared ... tried-and-true marker mesothelin is the best option available. Surviving ... Click here to read it now. , ... Diseases say, even though a mesothelin test can sometimes ... fibulin-3 for identifying mesothelioma. , “Preliminary results on ...
(Date:6/3/2015)... According to an article published on ... fake oxycodone pills which actually contained the potent addictive ... legitimate, and even sported the “A/215” imprint common on ... 30 mg oxycodone to be exceptionally critical of their ... them illegally on the street. Fentanyl is an opiate-based ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Fourroux Prosthetics, ... Duluth, GA will celebrate its grand opening with a ... The first prosthetic center of its kind in the ... family unmatched care and outcomes through use of patented ... CPO & CEO of Fourroux Prosthetics, states, “Our goal ...
(Date:6/3/2015)... MN (PRWEB) June 03, 2015 DailyEndorphin ... wellness "events" programming module. With this highly configurable ... run and report on many components of its wellness ... at no additional charge. , With this new module, ... Integrate DE challenges, (2) Create participant surveys, (3) Continually ...
Breaking Medicine News(10 mins):Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2
... Way to Fight Rare, but Deadly, Side Effect ... St. Luke,s Medical Center have developed a technique ... from natalizumab (Tysabri(R)), a drug that fights multiple ... called progressive multifocal leukoencephalopathy (PML)."This virus looks like ...
... J. Betters, president and chief executive officer of C. ... submitted an offer to purchase the former Aliquippa Hospital. ... awaiting a response from the hospital property owners and ... future uses for the hospital property., ...
... a woman blind in one eye. As she copes with ... uninjured eye begins to blur, and the eye becomes red ... ophthalmia, occurs when vision is lost in one eye through ... attacks the remaining healthy eye. Left untreated, a person can ...
... These patients were twice as likely to get clot-busting drug, ... who get to a hospital no more than an hour ... as likely to get the powerful clot-dissolving drug that is ... Of the more than 100,000 people treated for stroke at ...
... United BioSource Corporation (UBC) and CogState ... renew the strategic relationship the two companies ... CogState,s ClinicalTrials software for computerized cognitive testing ... and UBC remain committed to supporting cognitive ...
... Feb. 18 Spurred by seizures of vital doctor-prescribed ... Zealand to U.S. citizens, the publishers of three Seniors, ... Food and Drug Administration to halt the arbitrary seizures ... medicines to U.S. seniors and others.The publishers are Frank ...
Cached Medicine News:Health News:Research Brings New Hope to Multiple Sclerosis Patients 2Health News:New surgical implant tested at U-Iowa prevents total blindness 2Health News:Fast Arrival at Hospital After Stroke Pays Off 2Health News:Fast Arrival at Hospital After Stroke Pays Off 3Health News:Seniors' Website Publishers Ask President to Curtail FDA Seizures of Vital Medicines 2
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "2015 Strategies in ... to their offering. Highlights of the ... of the US tumor marker testing market. ... practice, as well as key economic, regulatory, demographic, ...
(Date:6/3/2015)... -- AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... that their customer, Pharmabox, has introduced the world,s 1 ... over 140 top selling brand name items typically found ... Aid-type store. As published in the ... -based Pharmabox worked with AVT to develop a ...
(Date:6/3/2015)... June 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and license agreement with AbbVie (NYSE: ABBV ... compounds with Halozyme,s ENHANZE ™ platform. ... Halozyme will receive an initial $23 million payment, ... for each of up to nine collaboration targets. ...
Breaking Medicine Technology:United States Strategies in the Tumor Marker Testing Market 2015 2Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3
... Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX) (the "Company") announced ... financing.  The new capital will primarily be used to fund working ... , , ... has been appointed as President, Chief Executive Officer and Board ...
... PRINCETON, N.J. , June 25 Soligenix, ... a late-stage biopharmaceutical company, announced today the publication of ... of Vaccine , which describes protection from mucosal ... of RiVax™, the Company,s vaccine against ricin toxin. The ...
Cached Medicine Technology:Patient Safety Technologies Completes $6.0 Million Equity Financing 2Patient Safety Technologies Completes $6.0 Million Equity Financing 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 2Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 4Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 5Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 6Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 7
VIKIA Rota-Adeno is a rapid, qualitative, chromatographic immunoassay which simultaneously detects rotaviruses and adenoviruses in stool specimens. Rotaviruses and adenoviruses are responsible for,th...
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
The ELISA test is used for detection and semi quantitation of igG antibodies to proteinase 3(PR3) in human sera, as an aid to the diagnosis is of Wegener's granulomatosis....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: